Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release May 27 2022

· Issued by Zydus Lifesciences Limited

Filed with NSE · · 2 pages · English

Summary by 6ix AI

Zydus Lifesciences Limited has issued a press release regarding the receipt of an Establishment Inspection Report from the USFDA for its injectables manufacturing facility at Jarod. The report indicates that the facility's inspection classification is Voluntary Action Indicated, and the inspection is considered closed. This inspection was a Pre-Approval cum cGMP inspection covering multiple Abbreviated New Drug Applications.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases